GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (STU:ECX) » Definitions » Cyclically Adjusted FCF per Share

Epigenomics AG (STU:ECX) Cyclically Adjusted FCF per Share : €-64.89 (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Epigenomics AG Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Epigenomics AG's adjusted free cash flow per share for the three months ended in Jun. 2023 was €-3.726. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-64.89 for the trailing ten years ended in Jun. 2023.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 13.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Epigenomics AG was 13.40% per year. The lowest was 3.20% per year. And the median was 7.80% per year.

As of today (2024-05-26), Epigenomics AG's current stock price is €1.59. Epigenomics AG's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 was €-64.89. Epigenomics AG's Cyclically Adjusted Price-to-FCF of today is .


Epigenomics AG Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Epigenomics AG's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG Cyclically Adjusted FCF per Share Chart

Epigenomics AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -99.76 -99.50 -92.87 -74.94 -65.66

Epigenomics AG Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -73.11 -76.10 -65.66 -67.14 -64.89

Competitive Comparison of Epigenomics AG's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Epigenomics AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epigenomics AG's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Epigenomics AG's Cyclically Adjusted Price-to-FCF falls into.



Epigenomics AG Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Epigenomics AG's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-3.726/123.1404*123.1404
=-3.726

Current CPI (Jun. 2023) = 123.1404.

Epigenomics AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201309 -16.057 98.983 -19.976
201312 -14.323 99.356 -17.752
201403 -15.206 99.543 -18.811
201406 -17.255 99.543 -21.346
201409 -22.957 99.823 -28.320
201412 -20.071 99.543 -24.829
201503 -21.185 99.717 -26.161
201506 -20.432 100.417 -25.056
201509 -15.702 100.417 -19.255
201512 -13.444 99.717 -16.602
201603 -18.415 100.017 -22.673
201606 -13.835 100.717 -16.915
201609 -31.706 101.017 -38.650
201612 -37.748 101.217 -45.924
201703 -9.866 101.417 -11.979
201706 -19.405 102.117 -23.400
201709 -16.602 102.717 -19.903
201712 -16.011 102.617 -19.213
201803 -15.439 102.917 -18.473
201806 -11.299 104.017 -13.376
201809 -17.140 104.718 -20.155
201812 -16.751 104.217 -19.793
201903 -15.710 104.217 -18.563
201906 -15.000 105.718 -17.472
201909 -13.498 106.018 -15.678
201912 -10.292 105.818 -11.977
202003 -11.920 105.718 -13.884
202006 -7.480 106.618 -8.639
202009 -6.719 105.818 -7.819
202012 -6.920 105.518 -8.076
202103 -8.125 107.518 -9.306
202106 -3.272 108.486 -3.714
202109 0.699 109.435 0.787
202112 -0.712 110.384 -0.794
202203 -4.277 113.968 -4.621
202206 -3.517 115.760 -3.741
202209 -3.247 118.818 -3.365
202212 -5.420 119.345 -5.592
202303 -3.862 122.402 -3.885
202306 -3.726 123.140 -3.726

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Epigenomics AG  (STU:ECX) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Epigenomics AG Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Epigenomics AG (STU:ECX) Business Description

Traded in Other Exchanges
Address
Geneststrasse 5, Berlin, BB, DEU, 10829
Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.